Exhibit A3. Number of prescriptions identified as disease-related by Prometheus, but not by ETG by National Drug Code (NDC) category.
| Diabetes | ||
|---|---|---|
| COUNT | PERCENT | |
| major_category1 | 2055 | 2.848 |
| cardiovascular agents | 15186 | 21.043 |
| antihyperlipidemic agents | 6510 | 9.021 |
| analgesics | 5682 | 7.873 |
| beta-adrenergic blocking agents | 5031 | 6.971 |
| antidepressants | 4526 | 6.272 |
| gastrointestinal agents | 3905 | 5.411 |
| diuretics | 3660 | 5.072 |
| hormones/hormone modifiers | 2599 | 3.601 |
| respiratory agents | 1845 | 2.557 |
| dermatological agents | 1693 | 2.346 |
| anti-infectives | 1672 | 2.317 |
| nutritional products | 1666 | 2.309 |
| penicillins | 1580 | 2.189 |
| antiarrhythmic agents | 1515 | 2.099 |
| ophthalmic preparations | 1329 | 1.842 |
| anticonvulsants | 1043 | 1.445 |
| nasal preparations | 882 | 1.222 |
| cephalosporins | 789 | 1.093 |
| anxiolytics, sedatives, and hypnotics | 774 | 1.073 |
| sex hormones | 760 | 1.053 |
| metabolic agents | 753 | 1.043 |
| macrolide derivatives | 719 | 0.996 |
| anticoagulants | 600 | 0.831 |
| bronchodilators | 561 | 0.777 |
| genitourinary tract agents | 477 | 0.661 |
| antiparkinson agents | 471 | 0.653 |
| antifungals | 405 | 0.561 |
| adrenal cortical steroids | 402 | 0.557 |
| immunosuppressive agents | 384 | 0.532 |
| muscle relaxants | 352 | 0.488 |
| antiplatelet agents | 351 | 0.486 |
| miscellaneous agents | 281 | 0.389 |
| central nervous system agents | 258 | 0.358 |
| antiviral agents | 231 | 0.320 |
| bone resorption inhibitors | 212 | 0.294 |
| otic preparations | 153 | 0.212 |
| antipsychotics | 114 | 0.158 |
| antineoplastics | 100 | 0.139 |
| antimalarial agents | 92 | 0.127 |
| respiratory inhalant products | 90 | 0.125 |
| antiemetic/antivertigo agents | 83 | 0.115 |
| antidiabetic agents | 70 | 0.097 |
| functional bowel disorder agents | 56 | 0.078 |
| topical agents | 53 | 0.073 |
| immunostimulants | 46 | 0.064 |
| coagulation modifiers | 40 | 0.055 |
| radiocontrast agents | 33 | 0.046 |
| vaginal preparations | 32 | 0.044 |
| biologicals | 30 | 0.042 |
| antituberculosis agents | 14 | 0.019 |
| alternative medicines | 2 | 0.003 |
| anticoagulants | 600 | 0.831 |
| bronchodilators | 561 | 0.777 |
| genitourinary tract agents | 477 | 0.661 |
| antiparkinson agents | 471 | 0.653 |
| antifungals | 405 | 0.561 |
| adrenal cortical steroids | 402 | 0.557 |
| immunosuppressive agents | 384 | 0.532 |
| muscle relaxants | 352 | 0.488 |
| antiplatelet agents | 351 | 0.486 |
| miscellaneous agents | 281 | 0.389 |
| central nervous system agents | 258 | 0.358 |
| antiviral agents | 231 | 0.320 |
| bone resorption inhibitors | 212 | 0.294 |
| otic preparations | 153 | 0.212 |
| antipsychotics | 114 | 0.158 |
| antineoplastics | 100 | 0.139 |
| antimalarial agents | 92 | 0.127 |
| respiratory inhalant products | 90 | 0.125 |
| antiemetic/antivertigo agents | 83 | 0.115 |
| antidiabetic agents | 70 | 0.097 |
| functional bowel disorder agents | 56 | 0.078 |
| topical agents | 53 | 0.073 |
| immunostimulants | 46 | 0.064 |
| coagulation modifiers | 40 | 0.055 |
| radiocontrast agents | 33 | 0.046 |
| vaginal preparations | 32 | 0.044 |
| biologicals | 30 | 0.042 |
| antituberculosis agents | 14 | 0.019 |
| alternative medicines | 2 | 0.003 |
SOURCE: Author’s analysis.